EFM
SLS icon

E Fund Management’s SELLAS Life Sciences SLS Stock Holding History

E Fund Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Buy
33,825
+2,471
+8% +$17.1K 0.01% 265
2026
Q1 		$133K Buy
+31,354
New +$140K ﹤0.01% 465

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

E Fund Management's SLS Position: Q2 2026 in Review

E Fund Management increased its SELLAS Life Sciences (SLS) stake by 7.9% in Q2 2026, buying an estimated $17.1K and bringing the position to 33,825 shares worth $499K. The position accounts for 0.01% of the portfolio, ranked #265.

E Fund Management first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • E Fund Management held 33,825 shares of SELLAS Life Sciences worth $499K as of Q2 2026.
  • E Fund Management bought 2,471 SELLAS Life Sciences shares in Q2 2026, an estimated $17.1K.
  • SELLAS Life Sciences made up 0.01% of E Fund Management's portfolio in Q2 2026, its #265 holding.
  • E Fund Management first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.